Ocuphire Pharma Inc (OCUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OCUP | MRNA | BMY | AMGN | GILD |
| Company | Ocuphire Pharma Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.9500 | 120.00 | 44.00 | 300.12 | 65.57 |
| High | 1.9500 | 122.83 | 44.22 | 306.11 | 65.61 |
| Low | 1.8400 | 119.50 | 43.67 | 298.89 | 64.97 |
| Last | 1.8800 | 121.89 | 43.66 | 304.45 | 65.08 |
| Change | -0.0600 | +0.82 | -0.38 | +4.15 | -0.38 |
| % Change | -3.09% | +0.68% | -0.86% | +1.38% | -0.58% |
| Volume | 62,577 | 1,098,191 | 4,369,340 | 1,081,257 | 1,772,792 |
| 20-Day Average Volume | 203,846 | 3,232,631 | 14,006,979 | 2,775,892 | 7,286,336 |
| Previous Close | 1.9400 | 121.07 | 44.04 | 300.30 | 65.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7235 | 110.53 | 46.40 | 277.14 | 66.31 |
| 20-Day Raw Stochastic | 63.11% | 75.23% | 5.41% | 69.40% | 15.65% |
| 20-Day Relative Strength | 49.51% | 63.37% | 29.04% | 64.49% | 33.21% |
| Weighted Alpha | -65.03 | +8.45 | -36.73 | +30.13 | -20.80 |
| Today's Opinion | 72% Sell | 100% Buy | 100% Sell | 56% Buy | 100% Sell |
| Previous Opinion | 72% Sell | 100% Buy | 100% Sell | 40% Buy | 100% Sell |
| Last Month's Opinion | 100% Sell | 88% Buy | 16% Sell | 8% Sell | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.94% since 05/01/24 | +9.01% since 05/01/24 | -1.10% since 05/01/24 | +9.48% since 05/01/24 | -0.68% since 05/01/24 |
| Low | 1.6500 on 05/02/24 | 114.06 on 05/02/24 | 43.33 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 |
| High | 2.1100 on 05/06/24 | 128.81 on 05/02/24 | 44.62 on 05/06/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 |
| 1-Month | |||||
| %Chg | +3.01% since 04/08/24 | +15.62% since 04/08/24 | -14.43% since 04/08/24 | +12.80% since 04/08/24 | -6.27% since 04/08/24 |
| Low | 1.5000 on 04/25/24 | 99.30 on 04/22/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 2.1100 on 05/06/24 | 128.81 on 05/02/24 | 51.68 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 |
| 3-Month | |||||
| %Chg | -25.20% since 02/08/24 | +29.72% since 02/08/24 | -10.23% since 02/08/24 | +2.99% since 02/08/24 | -11.84% since 02/08/24 |
| Low | 1.5000 on 04/25/24 | 84.06 on 02/13/24 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 |
| High | 2.7700 on 02/12/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 |
| 6-Month | |||||
| %Chg | -37.99% since 11/08/23 | +70.31% since 11/08/23 | -16.59% since 11/08/23 | +11.12% since 11/08/23 | -16.48% since 11/08/23 |
| Low | 1.5000 on 04/25/24 | 67.62 on 11/13/23 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 |
| High | 3.3994 on 01/10/24 | 128.81 on 05/02/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 49,681 | 46,398,864 | 89,273,480 | 161,091,424 | 81,502,736 |
| Shares Outstanding, K | 25,609 | 383,240 | 2,027,100 | 536,435 | 1,245,077 |
| Annual Sales | 19,050,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -9,990,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 1,690,000 | 167,000,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -4,800,000 | -1,175,000,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 |
| 60-Month Beta | 0.39 | 1.57 | 0.45 | 0.60 | 0.22 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 03/08/24 | -3.07 on 05/02/24 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 41.81 | 16.08 | 16.26 |